MANUEL
PRAGA TERENTE
Profesor emérito
Hospital Ramón y Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (24)
2024
-
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis
Kidney International, Vol. 105, Núm. 1, pp. 177-188
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation
Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 222-235
2022
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy
Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
2021
-
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Kidney International, Vol. 99, Núm. 4, pp. 986-998
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
-
Risk factors for non-diabetic renal disease in diabetic patients
Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388
2019
-
IgA nephropathy in elderly patients
Clinical Journal of the American Society of Nephrology, Vol. 14, Núm. 8, pp. 1183-1192
2018
-
Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis
Clinical Journal of the American Society of Nephrology, Vol. 13, Núm. 12, pp. 1851-1858
-
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
Kidney International Reports, Vol. 3, Núm. 1, pp. 122-132
2016
-
Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis
Clinical Kidney Journal, Vol. 9, Núm. 3, pp. 381-386
2015
-
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
Kidney International, Vol. 88, Núm. 5, pp. 1153-1160
2012
-
Diagnosis and treatment of Lupus nephritis: Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and the Spanish society of nephrology (S.E.N.)
Nefrologia, Vol. 32, Núm. SUPPL. 1, pp. 1-45
-
Diagnosis and treatment of lupus nephritis
Revista Clinica Espanola
-
Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria
Journal of the American Society of Nephrology, Vol. 23, Núm. 10, pp. 1753-1760
-
Nefritis lúpica: En busca de un futuro mejor
Nefrologia
2009
-
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32